Physician profile
Betsy Hughes Grunch
NPI 1265606644
$1,085,598.50
in general payments reported to CMS, 2019-2025
58 companies · $202K in 2025
The $202K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $73K · 2021: $101K · 2022: $133K · 2023: $191K · 2024: $278K · 2025: $202K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $244K · Consulting Fee: $217K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Travel and Lodging: $70K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $43K · Food and Beverage: $20K · Entertainment: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $244,180.71 |
| Consulting Fee | $217,461.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $76,437.90 |
| Travel and Lodging | $70,165.31 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $42,740.00 |
| Food and Beverage | $19,729.32 |
| Entertainment | $348.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hyhte Holdings INC. | $381,030.94 | 2019-2025 | Olympic Mis |
| Spineology INC. | $190,345.04 | 2019-2025 | Optimesh Expandable Interbody Fusion System |
| Acadia Pharmaceuticals INC | $112,000.00 | 2024-2025 | Nuplazid |
| Choice Spine, LLC | $108,706.81 | 2019-2025 | Harrier-Sa Lumbar Interbody System |
| Intrinsic Therapeutics | $52,046.54 | 2020-2025 | Barricaid Acd (Annular Closure Device) |
| Nevro Corp. | $48,744.71 | 2020-2024 | Senza, Omnia |
| Titan Spine, LLC | $32,223.46 | 2019 | |
| Mimedx Group, INC. | $25,844.79 | 2024-2025 | |
| Medacta USA, INC. | $22,850.12 | 2021-2025 | Myspine |
| Aesculap Implant Systems, LLC | $18,578.31 | 2019-2020 | |
| Medtronic, INC. | $18,381.58 | 2022-2024 | Unid_pass |
| Cerapedics INC. | $16,312.68 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $12,159.15 | 2022-2024 | Firebird Si, M6-C |
| Clariance Sas | $11,627.53 | 2019 | |
| Boston Scientific Corporation | $7,014.02 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $5,426.73 | 2023-2025 | |
| Stryker Corporation | $4,691.35 | 2021-2024 | Airo, Everest Spinal System, Avs Navigator |
| Gt Medical Technologies, INC | $3,783.71 | 2022-2025 | Gammatile, Gammatile |
| Centinel Spine, LLC | $2,222.78 | 2020-2024 | Prodisc L |
| Arthrex, INC. | $1,171.65 | 2024 | Arthrex |
| Highridge Medical LLC | $1,143.36 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System, Biomet Ebi Bone Healing System |
| Zimvie INC. | $1,125.88 | 2024 | |
| Brainlab, INC. | $960.19 | 2019-2022 | |
| United Orthopedics LLC | $929.14 | 2023-2024 | |
| 4web, INC. | $832.76 | 2025 | Spine Truss System |
| Alevio, LLC | $736.52 | 2019-2022 | |
| Clariance, INC. | $569.98 | 2019 | |
| Medtronic USA, INC. | $406.31 | 2019-2020 | |
| Elevation Spine, INC. | $324.63 | 2024-2025 | |
| Abbott Laboratories | $305.76 | 2019-2025 | Eterna, Freestyle Libre 2 |
| Corelink, LLC | $285.59 | 2021-2023 | |
| Kci USA, INC. | $279.70 | 2019 | |
| Radius Health, INC. | $257.58 | 2020-2025 | Tymlos |
| Zimmer Biomet Holdings, INC. | $248.39 | 2019 | |
| Providence Medical Technology, INC. | $228.12 | 2019-2025 | |
| Sanara Medtech INC. | $199.52 | 2020-2021 | |
| Ethicon US, LLC | $188.86 | 2019-2023 | Vistaseal, Evarrest, Surgicel Nu-Knit |
| Implanet America, INC. | $159.17 | 2025 | |
| Curiteva, INC. | $149.71 | 2021 | |
| Medical Device Business Services, INC. | $148.85 | 2019-2024 | Symphony, Teligen, Vivigen Mis Delivery System |
| Globus Medical, INC. | $148.78 | 2021 | |
| Depuy Synthes Sales INC. | $136.15 | 2021-2023 | Viper, X-Pac, Spine & Trauma 3d Navigation |
| Icotec Medical INC. | $127.50 | 2021 | |
| Spineguard, INC. | $100.00 | 2024 | |
| Wound Management Technologies, INC | $90.95 | 2019 | |
| Becton, Dickinson and Company | $74.05 | 2025 | Hemosphere, Channel Drain |
| Smith+Nephew, INC. | $57.67 | 2020-2025 | Renasys Touch, Pico 14 |
| Kyocera Medical Technologies, INC. | $53.39 | 2022 | |
| Xtant Medical INC | $36.37 | 2022 | |
| Spine Wave, INC. | $31.19 | 2023 | Proficient Posterior Cervical Spine System |
| Spr Therapeutics, INC | $20.69 | 2023 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $18.12 | 2019 | |
| Ethicon INC. | $17.33 | 2019 | |
| Zyla Life Sciences, INC. | $15.55 | 2019 | |
| Olympus America INC. | $14.85 | 2021 | |
| Integra Lifesciences Corporation | $13.99 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$62,499.08 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$409,405.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Grunch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.